Canada-EU drug patent demand in trade talks costs almost $2B
Monday, October 15, 2012 - 10:31
in Mathematics & Economics
Contrary to claims that a Canada-EU trade deal won't increase health costs, federal government officials have studied the European Union's trade demands on drug patents and calculated a potential cost of $795 million-$1.95 billion annually.